Consistent with a pathogenetic role of s-FasL, sera of LGLL patients were shown to induce in-vitro apoptosis of normal neutrophils; moreover, the clinical resolution of neutropenia in treated patients was associated with a reduction in s-FasL levels, which in most of cases resulted even undetectable [40,44]. The gene discussed is FASLG; the disease is neutropenia.